Skip to main content
Fig. 3 | Journal of Genetic Engineering and Biotechnology

Fig. 3

From: SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids

Fig. 3

AutoDock binding energies (Kcal/mol) of reference inhibitors and top bioactive terpenoids with human angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), ACE2-SARS-CoV-2 spike receptor binding domain complex (ACE2-RBD), and (*S P) spike protein of coronaviruses. S1 MLN-4760. S2 Camostat. S3 Nelfinavir mesylates. T1 24-methylene cycloartenol. T2 Isoiguesterin. T3 11-hydroxy-2-(3,4-dihydroxybenzoyloxy)abieta-5,7,9(11),13-tetraene-12-one. T4 11-hydroxy-2-(4-hydroxybenzoyloxy)-abieta-5,7,9(11),13-tetraene-12-one. T5 3-benzoylhosloppone. T6 Cucurbitacin B. T7 7-deacetoxy-7-oxogedunin. T8 3-Friedelanone

Back to article page